v3.26.1
Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows used in operating activities:    
Net loss $ (5,819,105) $ (7,512,667)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 1,059 5,918
Equity-based compensation 924,466 1,141,409
Changes in operating assets and liabilities:    
Interest receivable (209) 19,114
Prepaid expenses (209,965) (316,100)
Deferred offering costs 10,668 (9,416)
Other assets 1,624
Accounts payable 221,250 (606,859)
Accrued liabilities (363,535) (397,580)
Net cash used in operating activities (5,235,371) (7,674,557)
Cash flows from investing activities:    
Investment in property and equipment (3,251)
Disposal of property & equipment 1,441
Net cash provided by (used in) investing activities 1,441 (3,251)
Cash flows from financing activities:    
Proceeds from warrant inducements 2,570,274
Issuance costs from warrant inducement (338,667)
Proceeds from sale of common stock under ATM 1,458,088 3,347,618
Issuance costs for sale of common stock under ATM (75,419) (149,019)
Proceeds from exercise of stock options 31,997
Net cash provided by financing activities 3,614,276 3,230,596
Net change in cash and cash equivalents (1,619,654) (4,447,212)
Cash and cash equivalents – beginning of the period 4,007,789 10,017,942
Cash and cash equivalents – end of the period 2,388,135 5,570,730
Supplemental disclosure of non-cash financing activities:    
Receivable from issuance of warrants 2,684,904
Issuance costs under accrued expenses $ 51,560